Related Articles
FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1
miR-103 promotes the metastasis and EMT of hepatocellular carcinoma by directly inhibiting LATS2
Osteopontin promotes hepatocellular carcinoma progression via the PI3K/AKT/Twist signaling pathway
Upregulation of lncRNA Sox2ot indicates a poor prognosis for patients with hepatocellular carcinoma and promotes cell invasion
CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial‑mesenchymal transition